Oculus signs marketing deal with OroScience
Oculus Innovative Sciences has entered into an agreement with OroScience granting Oroscience exclusive rights to market Microcyn-based oral products in the U.S., Canada, and Europe in exchange for providing Oculus with a significant percentage of those revenues. OroScience will support all regulatory, clinical, sales, and marketing related to the Microcyn-based professional oral care products, with the first product launch anticipated in 2010, according to the companies. “We’ve identified a number

